Video

How High Cost Oncology Drugs Are Changing Specialty Pharmacy

Author(s):

Lauren Santye, Assistant Editor

Jonathan Van Lare, PharmD, director of Clinical Services at Pharmacy Advantage, discusses the impact of oncology medications and how specialty pharmacies can adjust.

Jonathan Van Lare, PharmD, director of Clinical Services at Pharmacy Advantage, discusses the impact of oncology medications and how specialty pharmacies can adjust.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Tired scared retiree man holding chest with anginal symptoms, pallor and diaphoresis at home. Suffering male with cardiac origin pain, prexcordial pressure, arrhythmia risk, urgent medical attention - Image credit: DimaBerlin | stock.adobe.com
Image credit: Sebastian Kaulitzki | stock.adobe.com
Magnified bone marrow biopsy showing plasma cells with irregular nuclei and multiple myeloma tumor cells infiltrating normal hematopoietic tissue.
Health and nutrition: the role of glp-1 in diabetes management with apple and syringe - Image credit: Thanayut | stock.adobe.com
Related Content
Nurse -- Image credit: Rawpixel.com | stock.adobe.com
June 17th 2025

The Value of a Medically Integrated Pharmacy to Maximize Cost Avoidance and Reduce Waste of Oral Oncolytic Medications

Douglas Braun, PharmD, CSP, RPh
S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk
June 3rd 2025

S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk

Alexandra Gerlach, Associate Editor
Kidneys affected by chronic kidney disease (CKD) -- Image credit: Crystal light | stock.adobe.com
June 17th 2025

Multi-Phenotype Approach Highlights Increased Power of cPCA When Identifying CKD-Related Loci

Gillian McGovern, Associate Editor
Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings
May 28th 2025

Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings

Alexandra Gerlach, Associate Editor
Scrabble blocks spelling out neutropenia -- Image credit: Fauzi | stock.adobe.com
June 16th 2025

Impact of Patient Access to Care on Rates of Febrile Neutropenia Post Inpatient Administration of a Colony-Stimulating Factor

Adam Musante, PharmD Marissa Aquino, PharmD Meredith Vigneaux, PharmD
Pharmacist administering IV in patient -- Image credit: Elnur | stock.adobe.com
June 16th 2025

Impact of a Community-Based Specialty Pharmacist in Identifying Drug Therapy Problems for New Adult Oncology Patients

Emma Hilgendorf, PharmD Danielle Chapman, PharmD Sarah Schmidt, PharmD Kajua Lor, PharmD, BCACP Kristin Busse, PharmD, BCPS